Unknown

Dataset Information

0

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?


ABSTRACT: Childhood-onset systemic lupus erythematosus (cSLE) is an incurable multi-systemic autoimmune disease. Interferon type I (IFN-I) plays a pivotal role in the pathogenesis of SLE. The objective of this study was to assess the prevalence of the IFN-I signature and the contribution of cytosolic nucleic acid receptors to IFN-I activation in a cohort of primarily white cSLE patients.The IFN-I score (positive or negative), as a measure of IFN-I activation, was assessed using real-time quantitative PCR (RT-PCR) expression values of IFN-I signature genes (IFI44, IFI44L, IFIT1, Ly6e, MxA, IFITM1) in CD14+ monocytes of cSLE patients and healthy controls (HCs). Innate immune receptor expression was determined by RT-PCR and flow cytometry. To clarify the contribution of RNA-binding RIG-like receptors (RLRs) and DNA-binding receptors (DBRs) to IFN-I activation, peripheral blood mononuclear cells (PBMCs) from patients were treated with BX795, a TANK-binding kinase 1 (TBK1) inhibitor blocking RLR and DBR pathways.The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs. Upregulated gene expression of TLR7, RLRs (IFIH1, DDX58, DDX60, DHX58) and DBRs (ZBP-1, IFI16) was observed in CD14+ monocytes of the IFN-I-positive cSLE patients. Additionally, RIG-I and ZBP-1 protein expression was upregulated in these cells. Spontaneous IFN-I stimulated gene (ISG) expression in PBMCs from cSLE patients was inhibited by a TBK1-blocker.IFN-I activation, assessed as ISG expression, in cSLE is associated with increased expression of TLR7, and RNA and DNA binding receptors, and these receptors contribute to IFN-I activation via TBK1 signaling. TBK1-blockers may therefore be a promising treatment target for SLE.

SUBMITTER: Wahadat MJ 

PROVIDER: S-EPMC5763828 | biostudies-other | 2018 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?

Wahadat M Javad MJ   Bodewes Iris L A ILA   Maria Naomi I NI   van Helden-Meeuwsen Cornelia G CG   van Dijk-Hummelman Annette A   Steenwijk Eline C EC   Kamphuis Sylvia S   Versnel Marjan A MA  

Arthritis research & therapy 20180110 1


<h4>Background</h4>Childhood-onset systemic lupus erythematosus (cSLE) is an incurable multi-systemic autoimmune disease. Interferon type I (IFN-I) plays a pivotal role in the pathogenesis of SLE. The objective of this study was to assess the prevalence of the IFN-I signature and the contribution of cytosolic nucleic acid receptors to IFN-I activation in a cohort of primarily white cSLE patients.<h4>Methods</h4>The IFN-I score (positive or negative), as a measure of IFN-I activation, was assesse  ...[more]

Similar Datasets

| S-EPMC3920748 | biostudies-literature
| S-EPMC3978647 | biostudies-literature
| S-EPMC4720587 | biostudies-literature
| S-EPMC10374253 | biostudies-literature
| S-EPMC9038612 | biostudies-literature
| S-EPMC3672722 | biostudies-literature
| S-EPMC3275113 | biostudies-other
| S-EPMC2909403 | biostudies-literature
| S-EPMC6257379 | biostudies-other
| S-EPMC2214826 | biostudies-other